Skip to main content
Log in

Levofloxacin reduces LOS and costs in CAP

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Schein J, Janagap-Benson C, Grant R, Sikirica V, Doshi D, Olson W.A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay. Current Medical Research and Opinion 24: 895-906, No. 3, Mar 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levofloxacin reduces LOS and costs in CAP. Pharmacoecon. Outcomes News 549, 5 (2008). https://doi.org/10.2165/00151234-200805490-00011

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805490-00011

Keywords

Navigation